Scott Investment Partners’s Biogen BIIB Stock Holding History

Scott Investment Partners’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$797K	Hold	3,100	–	–	1.83%	35
2023 Q2	$883K	Hold	3,100	–	–	1.99%	29
2023 Q1	$862K	Hold	3,100	–	–	1.99%	27
2022 Q4	$858K	Hold	3,100	–	–	2.07%	27
2022 Q3	$828K	Hold	3,100	–	–	2.22%	20
2022 Q2	$632K	Hold	3,100	–	–	0.42%	39
2022 Q1	$653K	Hold	3,100	–	–	0.39%	38
2021 Q4	$744K	Hold	3,100	–	–	0.46%	35
2021 Q3	$877K	Hold	3,100	–	–	0.6%	33
2021 Q2	$1.07M	Hold	3,100	–	–	0.75%	29
2021 Q1	$867K	Buy	3,100 +500	+19%	+$135K	0.64%	32
2020 Q4	$637K	Buy	+2,600	New	+$671K	0.5%	35

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Scott Investment Partners's BIIB Position: Q3 2023 in Review

Scott Investment Partners held its Biogen (BIIB) position steady in Q3 2023 at 3,100 shares worth $797K. The position accounts for 1.83% of the portfolio, ranked #35.

Scott Investment Partners first reported a position in BIIB in Q4 2020 and has held it in 12 quarters since. The position peaked at $1.07M in Q2 2021. 966 funds tracked by Wall St. Rank hold BIIB as of Q3 2023.

Scott Investment Partners held 3,100 shares of Biogen worth $797K as of Q3 2023.
Scott Investment Partners left its Biogen share count unchanged in Q3 2023.
Biogen made up 1.83% of Scott Investment Partners's portfolio in Q3 2023, its #35 holding.
Scott Investment Partners first reported a position in Biogen in Q4 2020 and has held it in 12 quarters since.
Scott Investment Partners's Biogen position peaked at $1.07M in Q2 2021.
966 funds tracked by Wall St. Rank held Biogen as of Q3 2023.

Based on Scott Investment Partners's 13F filing for Q3 2023, filed 1 Nov 2023.